Colebrook Bosson Saunders (CBS), a leader in workplace ergonomics, today officially launches Lana, a next-generation laptop stand that combines ergonomic performance with circular design principles.

Integrity, LLC ("Integrity"), a leading distributor of life and health insurance, and provider of wealth management and retirement planning solutions, today announced it has partnered with The ...

Distributors and OEM brands are scrutinizing their supply chain to ensure quality and viability over the long term as the global energy shift accelerates. In recent years, the 48V lithium battery ...

For the past two years, China’s PV manufacturers have been locked in a cycle of intense competition and price wars.

KYOTO, Japan, Jan. 20, 2026 /PRNewswire/ -- ROHM Co., Ltd. has developed the 100V power MOSFET--RS7P200BM--achieving industry-leading safe operating area (SOA) performance in a 5060-size (5.0mm x ...

A “standard reference thermoelectric module (SRTEM)*” for objectively measuring thermoelectric module performance has been developed in Korea for the first time. A research team led by Dr. Sang Hyun ...

Some things will remain the same for Vertex five years from now, including its dominance in treating cystic fibrosis (CF). However, the company will likely achieve success in several new markets ...

Bruker Corporation today announced the launch of the VERTEX NEO Ultra, its most advanced and versatile benchtop vacuum Fourier-Transform Infrared (FT-IR) spectrometer. Building on the VERTEX NEO ...

Vertex delivered a split result this morning that left investors parsing mixed signals. The tax technology provider beat on EPS but missed revenue expectations. Shares were down nearly 10% by the ...

Vertex, Inc. shares have plunged over 60% YTD, but valuation is now compelling after a post-earnings dip. VERX offers steady low-teens growth, expanding margins, and a sticky tax compliance software ...

Pfizer is racing towards patent cliffs that will lead to even worse financial results. Vertex Pharmaceuticals is posting strong revenue growth and excellent clinical progress. Pfizer's financial ...